ARRY-502

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameARRY-502
Drug Alias NameARRY-502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor antagonistsProstaglandin D2 receptor 2 antagonists
TargetsProstaglandin D2 receptorProstaglandin D2 receptor 2
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArray Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncArray Biopharma Inc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A